Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-15
Target enrollment:
Participant gender:
Summary
A phase 2 study to assess the efficacy of NA-931 alone or in addition to Tirzepatide to assess efficacy and safety in overweight or obese men and women